↓ Skip to main content

The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case Study

Overview of attention for article published in PharmacoEconomics, May 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

blogs
1 blog
twitter
9 X users
facebook
2 Facebook pages

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
88 Mendeley
Title
The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case Study
Published in
PharmacoEconomics, May 2018
DOI 10.1007/s40273-018-0673-y
Pubmed ID
Authors

José Leal, Stefania Manetti, James Buchanan

Abstract

Several methods exist to cost hospital contacts when estimating the cost effectiveness of a new intervention. However, the implications of choosing a particular approach remain unclear. We compare the use of the three main diagnosis-related group (DRG)-based national unit costs in England to determine whether choice of approach can impact on economic evaluation results. A cost-utility model was developed to compare secondary fracture prevention models of care for hip fracture patients, using data from large primary and hospital care administrative datasets in England. A healthcare and personal social services payer perspective was adopted, and utilities were informed by a meta-regression. Hospital resource use was valued using three DRG-based unit costs, and regression-based costing models were developed using data from 13,906 patients to inform the model health states. Finished consultant episode (FCE)-level reference costs resulted in the highest costs on admission (£9075) and in the year of the fracture (£14,440). Relative to FCE-level costs, spell-level tariffs led to the lowest total hospital care costs per patient within 1 year of fracture (- £3691) compared with spell-level reference costs (- £2106). At a £20,000/quality-adjusted life-year threshold, using spell-level reference costs or spell-level tariffs, the introduction of a nurse-led fracture liaison service model of care was the cost-effective alternative. However, using FCE-level reference costs, usual care was the cost-effective option. Our results show that, conditional on the set of national unit costs adopted, the costs of hip fracture may vary considerably and different decisions may be reached regarding the introduction of new healthcare interventions.

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 88 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 88 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 13 15%
Student > Master 13 15%
Researcher 10 11%
Student > Bachelor 10 11%
Other 6 7%
Other 12 14%
Unknown 24 27%
Readers by discipline Count As %
Medicine and Dentistry 20 23%
Nursing and Health Professions 13 15%
Economics, Econometrics and Finance 10 11%
Pharmacology, Toxicology and Pharmaceutical Science 5 6%
Business, Management and Accounting 3 3%
Other 12 14%
Unknown 25 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 June 2018.
All research outputs
#2,488,847
of 23,322,258 outputs
Outputs from PharmacoEconomics
#216
of 1,876 outputs
Outputs of similar age
#53,963
of 330,805 outputs
Outputs of similar age from PharmacoEconomics
#7
of 38 outputs
Altmetric has tracked 23,322,258 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,876 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 330,805 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.